Luigina Guasti Selected Research

Luigina Guasti Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2021 - 03/2002
5	Neoplasms (Cancer) 03/2021 - 01/2017
5	Dyslipidemias (Dyslipidemia) 09/2018 - 01/2011
5	Venous Thromboembolism 01/2018 - 05/2010
4	Inflammation (Inflammations) 12/2019 - 05/2006
4	Atrial Fibrillation 01/2018 - 08/2011
4	Atherosclerosis 01/2016 - 05/2007
3	Stroke (Strokes) 08/2019 - 07/2013
3	Acute Coronary Syndrome 09/2018 - 10/2011
3	Pulmonary Embolism 08/2017 - 07/2013
3	Essential Hypertension 02/2017 - 11/2002
3	Metabolic Syndrome (Dysmetabolic Syndrome X) 09/2014 - 02/2006
3	Hypothyroidism 01/2014 - 02/2006
3	Heart Diseases (Heart Disease) 01/2014 - 01/2006
3	Hypertrophy 01/2012 - 11/2006
2	Non-alcoholic Fatty Liver Disease 01/2022 - 11/2011
2	Ischemic Stroke 08/2019 - 01/2018
2	ST Elevation Myocardial Infarction 09/2018 - 01/2018
2	Chronic Hepatitis C 01/2018 - 12/2014
2	Hemorrhage 01/2018 - 04/2015
2	Thrombosis (Thrombus) 04/2015 - 07/2013
2	Peripheral Arterial Disease 01/2013 - 12/2009
2	Type 2 Diabetes Mellitus (MODY) 12/2012 - 04/2005
2	Thyroid Neoplasms (Thyroid Cancer) 07/2007 - 02/2006
2	Pain (Aches) 07/2007 - 03/2002
2	Insulin Resistance 04/2007 - 04/2005
1	Hyperlipidemias (Hyperlipidemia) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2021
1	Breast Neoplasms (Breast Cancer) 03/2021
1	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 03/2021
1	Hematologic Neoplasms (Hematological Malignancy) 03/2021
1	Cardiotoxicity 03/2021
1	Heart Failure 01/2021
1	Vascular Diseases (Vascular Disease) 12/2019
1	Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left) 12/2019
1	Myocardial Ischemia (Ischemic Heart Diseases) 08/2019
1	Diabetes Mellitus 08/2019
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 12/2018
1	Vitamin D Deficiency 10/2018
1	Colonic Neoplasms (Colon Cancer) 10/2018
1	Carcinoma (Carcinomatosis) 10/2018
1	Colorectal Neoplasms (Colorectal Cancer) 10/2018
1	Non-ST Elevated Myocardial Infarction 09/2018
1	Coronary Disease (Coronary Heart Disease) 09/2018
1	Chronic Hepatitis (Chronic Active Hepatitis) 01/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2018
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 10/2017
1	Necrosis 01/2017
1	Embolism (Embolus) 10/2015

Drug/Important Bio-Agent (IBA)

8	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2017 - 05/2007
7	Antihypertensive Agents (Antihypertensives)IBA 10/2007 - 03/2002
6	LipidsIBA 09/2018 - 04/2005
5	oxidized low density lipoproteinIBA 01/2022 - 04/2005
4	AnticoagulantsIBA 01/2018 - 12/2014
4	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 01/2017 - 03/2002
3	LDL CholesterolIBA 09/2018 - 11/2011
2	PCSK9 InhibitorsIBA 01/2022 - 10/2017
2	Vitamin D FDA LinkGeneric 12/2018 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2018 - 01/2012
2	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 11/2011
2	CanrenoneIBA 01/2017 - 11/2002
2	Matrix Metalloproteinases (MMPs)IBA 01/2017 - 01/2012
2	Pharmaceutical PreparationsIBA 04/2015 - 03/2002
2	Apolipoproteins B (ApoB)IBA 09/2014 - 04/2005
2	Interleukin-8 (Interleukin 8)IBA 03/2014 - 12/2009
2	Thyroid HormonesIBA 01/2014 - 07/2007
2	Fibric Acids (Fibrates)IBA 12/2012 - 05/2010
2	Type 1 Angiotensin ReceptorIBA 12/2009 - 05/2006
2	Enalapril FDA LinkGeneric 04/2005 - 03/2002
1	AnthracyclinesIBA 03/2021
1	Neprilysin (Neutral Endopeptidase)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 01/2021
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 01/2021
1	Antineoplastic Agents (Antineoplastics)IBA 01/2021
1	Rituximab (Mabthera)FDA Link 01/2021
1	Receptor for Advanced Glycation End ProductsIBA 12/2019
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 08/2019
1	Tyrosine Kinase InhibitorsIBA 12/2018
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 10/2018
1	Cetuximab (Erbitux)FDA Link 10/2018
1	VitaminsIBA 10/2018
1	ErbB Receptors (EGF Receptor)IBA 10/2018
1	Monoclonal AntibodiesIBA 10/2018
1	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 09/2018
1	omega-Chloroacetophenone (Mace)IBA 09/2018
1	Clopidogrel (Plavix)FDA Link 01/2018
1	Antiviral Agents (Antivirals)IBA 01/2018
1	4- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA 06/2017
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 02/2017
1	Messenger RNA (mRNA)IBA 01/2017
1	apixabanIBA 01/2017

Therapy/Procedure

14	Therapeutics 01/2022 - 04/2005
3	Percutaneous Coronary Intervention 01/2018 - 10/2011
2	Drug Therapy (Chemotherapy) 03/2021 - 10/2018
2	Secondary Prevention 08/2019 - 01/2018
2	Length of Stay 01/2018 - 08/2017
2	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 04/2015 - 10/2011
1	Ambulatory Care (Outpatient Care) 12/2019
1	Stents 04/2015